|
private:reliantheart
|
3511403
|
Dec 3rd, 2020 12:00AM
|
ReliantHeart Inc.
|
507
|
15.00
|
Open
|
Medical Device
|
Dec 3rd, 2020 12:39PM
|
Dec 3rd, 2020 12:39PM
|
ReliantHeart, Inc. is a leading innovator in mechanical circulatory support therapies for advanced stage heart failure. The company manufactures the aVAD®, a next generation ventricular assist device (VAD) which has been granted CE Mark approval for commercial sale in Europe.
The aVAD® is an implantable, electric pump designed for use in patients requiring ventricular support due to end stage heart failure and is the world’s only fully remotely monitored VAD. ReliantHeart is privately held and headquartered in Houston, Texas. For more information please visit www.reliantheart.com
ReliantHeart recently integrated the feature for continuous wireless monitoring into its Conquest Controller. This unprecedented innovation will allow continual remote monitoring of data from the aVAD®. As a result, clinicians and technicians will be informed automatically and in the background about the performance of the LVAD without requiring patient interaction or a trip to the clinic or hospital facilities.
The aVAD® is the smallest and lightest full support LVAD in the world, weighing only 84 grams, and it is silent. Because of its miniature size, it can be implanted above the diaphragm, adjacent to the heart. The aVAD® is the most technically advanced device among just two other competitors in this field; it is the only LVAD with a precise, direct flow measurement system and cellular-based remote monitoring.
|
Open
|
|
Open
|
8965 Interchange
|
Houston
|
Texas
|
US
|
77054
|
|
ReliantHeart
|
|
Health Care Equipment & Services
|
|
private:reliantheart
|
3511403
|
Dec 2nd, 2020 12:00AM
|
ReliantHeart Inc.
|
507
|
15.00
|
Open
|
Medical Device
|
Dec 2nd, 2020 03:03PM
|
Dec 2nd, 2020 03:03PM
|
ReliantHeart, Inc. is a leading innovator in mechanical circulatory support therapies for advanced stage heart failure. The company manufactures the aVAD®, a next generation ventricular assist device (VAD) which has been granted CE Mark approval for commercial sale in Europe.
The aVAD® is an implantable, electric pump designed for use in patients requiring ventricular support due to end stage heart failure and is the world’s only fully remotely monitored VAD. ReliantHeart is privately held and headquartered in Houston, Texas. For more information please visit www.reliantheart.com
ReliantHeart recently integrated the feature for continuous wireless monitoring into its Conquest Controller. This unprecedented innovation will allow continual remote monitoring of data from the aVAD®. As a result, clinicians and technicians will be informed automatically and in the background about the performance of the LVAD without requiring patient interaction or a trip to the clinic or hospital facilities.
The aVAD® is the smallest and lightest full support LVAD in the world, weighing only 84 grams, and it is silent. Because of its miniature size, it can be implanted above the diaphragm, adjacent to the heart. The aVAD® is the most technically advanced device among just two other competitors in this field; it is the only LVAD with a precise, direct flow measurement system and cellular-based remote monitoring.
|
Open
|
|
Open
|
8965 Interchange
|
Houston
|
Texas
|
US
|
77054
|
|
ReliantHeart
|
|
Health Care Equipment & Services
|
|
private:reliantheart
|
3511403
|
Dec 1st, 2020 12:00AM
|
ReliantHeart Inc.
|
507
|
15.00
|
Open
|
Medical Device
|
Dec 1st, 2020 02:25PM
|
Dec 1st, 2020 02:25PM
|
ReliantHeart, Inc. is a leading innovator in mechanical circulatory support therapies for advanced stage heart failure. The company manufactures the aVAD®, a next generation ventricular assist device (VAD) which has been granted CE Mark approval for commercial sale in Europe.
The aVAD® is an implantable, electric pump designed for use in patients requiring ventricular support due to end stage heart failure and is the world’s only fully remotely monitored VAD. ReliantHeart is privately held and headquartered in Houston, Texas. For more information please visit www.reliantheart.com
ReliantHeart recently integrated the feature for continuous wireless monitoring into its Conquest Controller. This unprecedented innovation will allow continual remote monitoring of data from the aVAD®. As a result, clinicians and technicians will be informed automatically and in the background about the performance of the LVAD without requiring patient interaction or a trip to the clinic or hospital facilities.
The aVAD® is the smallest and lightest full support LVAD in the world, weighing only 84 grams, and it is silent. Because of its miniature size, it can be implanted above the diaphragm, adjacent to the heart. The aVAD® is the most technically advanced device among just two other competitors in this field; it is the only LVAD with a precise, direct flow measurement system and cellular-based remote monitoring.
|
Open
|
|
Open
|
8965 Interchange
|
Houston
|
Texas
|
US
|
77054
|
|
ReliantHeart
|
|
Health Care Equipment & Services
|
|
private:reliantheart
|
3511403
|
Nov 30th, 2020 12:00AM
|
ReliantHeart Inc.
|
507
|
15.00
|
Open
|
Medical Device
|
Nov 29th, 2020 08:28PM
|
Nov 30th, 2020 03:16PM
|
ReliantHeart, Inc. is a leading innovator in mechanical circulatory support therapies for advanced stage heart failure. The company manufactures the aVAD®, a next generation ventricular assist device (VAD) which has been granted CE Mark approval for commercial sale in Europe.
The aVAD® is an implantable, electric pump designed for use in patients requiring ventricular support due to end stage heart failure and is the world’s only fully remotely monitored VAD. ReliantHeart is privately held and headquartered in Houston, Texas. For more information please visit www.reliantheart.com
ReliantHeart recently integrated the feature for continuous wireless monitoring into its Conquest Controller. This unprecedented innovation will allow continual remote monitoring of data from the aVAD®. As a result, clinicians and technicians will be informed automatically and in the background about the performance of the LVAD without requiring patient interaction or a trip to the clinic or hospital facilities.
The aVAD® is the smallest and lightest full support LVAD in the world, weighing only 84 grams, and it is silent. Because of its miniature size, it can be implanted above the diaphragm, adjacent to the heart. The aVAD® is the most technically advanced device among just two other competitors in this field; it is the only LVAD with a precise, direct flow measurement system and cellular-based remote monitoring.
|
Open
|
|
Open
|
8965 Interchange
|
Houston
|
Texas
|
US
|
77054
|
|
ReliantHeart
|
|
Health Care Equipment & Services
|
|
private:reliantheart
|
3511403
|
Nov 28th, 2020 12:00AM
|
ReliantHeart Inc.
|
507
|
15.00
|
Open
|
Medical Device
|
Nov 28th, 2020 04:04PM
|
Nov 28th, 2020 04:04PM
|
ReliantHeart, Inc. is a leading innovator in mechanical circulatory support therapies for advanced stage heart failure. The company manufactures the aVAD®, a next generation ventricular assist device (VAD) which has been granted CE Mark approval for commercial sale in Europe.
The aVAD® is an implantable, electric pump designed for use in patients requiring ventricular support due to end stage heart failure and is the world’s only fully remotely monitored VAD. ReliantHeart is privately held and headquartered in Houston, Texas. For more information please visit www.reliantheart.com
ReliantHeart recently integrated the feature for continuous wireless monitoring into its Conquest Controller. This unprecedented innovation will allow continual remote monitoring of data from the aVAD®. As a result, clinicians and technicians will be informed automatically and in the background about the performance of the LVAD without requiring patient interaction or a trip to the clinic or hospital facilities.
The aVAD® is the smallest and lightest full support LVAD in the world, weighing only 84 grams, and it is silent. Because of its miniature size, it can be implanted above the diaphragm, adjacent to the heart. The aVAD® is the most technically advanced device among just two other competitors in this field; it is the only LVAD with a precise, direct flow measurement system and cellular-based remote monitoring.
|
Open
|
|
Open
|
8965 Interchange
|
Houston
|
Texas
|
US
|
77054
|
|
ReliantHeart
|
|
Health Care Equipment & Services
|
|
private:reliantheart
|
3511403
|
Nov 27th, 2020 12:00AM
|
ReliantHeart Inc.
|
507
|
15.00
|
Open
|
Medical Device
|
Nov 27th, 2020 12:29PM
|
Nov 27th, 2020 12:29PM
|
ReliantHeart, Inc. is a leading innovator in mechanical circulatory support therapies for advanced stage heart failure. The company manufactures the aVAD®, a next generation ventricular assist device (VAD) which has been granted CE Mark approval for commercial sale in Europe.
The aVAD® is an implantable, electric pump designed for use in patients requiring ventricular support due to end stage heart failure and is the world’s only fully remotely monitored VAD. ReliantHeart is privately held and headquartered in Houston, Texas. For more information please visit www.reliantheart.com
ReliantHeart recently integrated the feature for continuous wireless monitoring into its Conquest Controller. This unprecedented innovation will allow continual remote monitoring of data from the aVAD®. As a result, clinicians and technicians will be informed automatically and in the background about the performance of the LVAD without requiring patient interaction or a trip to the clinic or hospital facilities.
The aVAD® is the smallest and lightest full support LVAD in the world, weighing only 84 grams, and it is silent. Because of its miniature size, it can be implanted above the diaphragm, adjacent to the heart. The aVAD® is the most technically advanced device among just two other competitors in this field; it is the only LVAD with a precise, direct flow measurement system and cellular-based remote monitoring.
|
Open
|
|
Open
|
8965 Interchange
|
Houston
|
Texas
|
US
|
77054
|
|
ReliantHeart
|
|
Health Care Equipment & Services
|
|
private:reliantheart
|
3511403
|
Nov 26th, 2020 12:00AM
|
ReliantHeart Inc.
|
507
|
15.00
|
Open
|
Medical Device
|
Nov 25th, 2020 07:12PM
|
Nov 26th, 2020 01:28PM
|
ReliantHeart, Inc. is a leading innovator in mechanical circulatory support therapies for advanced stage heart failure. The company manufactures the aVAD®, a next generation ventricular assist device (VAD) which has been granted CE Mark approval for commercial sale in Europe.
The aVAD® is an implantable, electric pump designed for use in patients requiring ventricular support due to end stage heart failure and is the world’s only fully remotely monitored VAD. ReliantHeart is privately held and headquartered in Houston, Texas. For more information please visit www.reliantheart.com
ReliantHeart recently integrated the feature for continuous wireless monitoring into its Conquest Controller. This unprecedented innovation will allow continual remote monitoring of data from the aVAD®. As a result, clinicians and technicians will be informed automatically and in the background about the performance of the LVAD without requiring patient interaction or a trip to the clinic or hospital facilities.
The aVAD® is the smallest and lightest full support LVAD in the world, weighing only 84 grams, and it is silent. Because of its miniature size, it can be implanted above the diaphragm, adjacent to the heart. The aVAD® is the most technically advanced device among just two other competitors in this field; it is the only LVAD with a precise, direct flow measurement system and cellular-based remote monitoring.
|
Open
|
|
Open
|
8965 Interchange
|
Houston
|
Texas
|
US
|
77054
|
|
ReliantHeart
|
|
Health Care Equipment & Services
|
|
private:reliantheart
|
3511403
|
Nov 24th, 2020 12:00AM
|
ReliantHeart Inc.
|
507
|
15.00
|
Open
|
Medical Device
|
Nov 24th, 2020 02:34PM
|
Nov 24th, 2020 02:34PM
|
ReliantHeart, Inc. is a leading innovator in mechanical circulatory support therapies for advanced stage heart failure. The company manufactures the aVAD®, a next generation ventricular assist device (VAD) which has been granted CE Mark approval for commercial sale in Europe.
The aVAD® is an implantable, electric pump designed for use in patients requiring ventricular support due to end stage heart failure and is the world’s only fully remotely monitored VAD. ReliantHeart is privately held and headquartered in Houston, Texas. For more information please visit www.reliantheart.com
ReliantHeart recently integrated the feature for continuous wireless monitoring into its Conquest Controller. This unprecedented innovation will allow continual remote monitoring of data from the aVAD®. As a result, clinicians and technicians will be informed automatically and in the background about the performance of the LVAD without requiring patient interaction or a trip to the clinic or hospital facilities.
The aVAD® is the smallest and lightest full support LVAD in the world, weighing only 84 grams, and it is silent. Because of its miniature size, it can be implanted above the diaphragm, adjacent to the heart. The aVAD® is the most technically advanced device among just two other competitors in this field; it is the only LVAD with a precise, direct flow measurement system and cellular-based remote monitoring.
|
Open
|
|
Open
|
8965 Interchange
|
Houston
|
Texas
|
US
|
77054
|
|
ReliantHeart
|
|
Health Care Equipment & Services
|
|
private:reliantheart
|
3511403
|
Nov 23rd, 2020 12:00AM
|
ReliantHeart Inc.
|
507
|
15.00
|
Open
|
Medical Device
|
Nov 23rd, 2020 04:32PM
|
Nov 23rd, 2020 04:32PM
|
ReliantHeart, Inc. is a leading innovator in mechanical circulatory support therapies for advanced stage heart failure. The company manufactures the aVAD®, a next generation ventricular assist device (VAD) which has been granted CE Mark approval for commercial sale in Europe.
The aVAD® is an implantable, electric pump designed for use in patients requiring ventricular support due to end stage heart failure and is the world’s only fully remotely monitored VAD. ReliantHeart is privately held and headquartered in Houston, Texas. For more information please visit www.reliantheart.com
ReliantHeart recently integrated the feature for continuous wireless monitoring into its Conquest Controller. This unprecedented innovation will allow continual remote monitoring of data from the aVAD®. As a result, clinicians and technicians will be informed automatically and in the background about the performance of the LVAD without requiring patient interaction or a trip to the clinic or hospital facilities.
The aVAD® is the smallest and lightest full support LVAD in the world, weighing only 84 grams, and it is silent. Because of its miniature size, it can be implanted above the diaphragm, adjacent to the heart. The aVAD® is the most technically advanced device among just two other competitors in this field; it is the only LVAD with a precise, direct flow measurement system and cellular-based remote monitoring.
|
Open
|
|
Open
|
8965 Interchange
|
Houston
|
Texas
|
US
|
77054
|
|
ReliantHeart
|
|
Health Care Equipment & Services
|
|
private:reliantheart
|
3511403
|
Nov 22nd, 2020 12:00AM
|
ReliantHeart Inc.
|
507
|
15.00
|
Open
|
Medical Device
|
Nov 22nd, 2020 03:30PM
|
Nov 22nd, 2020 03:30PM
|
ReliantHeart, Inc. is a leading innovator in mechanical circulatory support therapies for advanced stage heart failure. The company manufactures the aVAD®, a next generation ventricular assist device (VAD) which has been granted CE Mark approval for commercial sale in Europe.
The aVAD® is an implantable, electric pump designed for use in patients requiring ventricular support due to end stage heart failure and is the world’s only fully remotely monitored VAD. ReliantHeart is privately held and headquartered in Houston, Texas. For more information please visit www.reliantheart.com
ReliantHeart recently integrated the feature for continuous wireless monitoring into its Conquest Controller. This unprecedented innovation will allow continual remote monitoring of data from the aVAD®. As a result, clinicians and technicians will be informed automatically and in the background about the performance of the LVAD without requiring patient interaction or a trip to the clinic or hospital facilities.
The aVAD® is the smallest and lightest full support LVAD in the world, weighing only 84 grams, and it is silent. Because of its miniature size, it can be implanted above the diaphragm, adjacent to the heart. The aVAD® is the most technically advanced device among just two other competitors in this field; it is the only LVAD with a precise, direct flow measurement system and cellular-based remote monitoring.
|
Open
|
|
Open
|
8965 Interchange
|
Houston
|
Texas
|
US
|
77054
|
|
ReliantHeart
|
|
Health Care Equipment & Services
|